Selected research
Industry Growth & Trends
Global Oxiracetam API Industry Growth and Trends Forecast to 2032
Market perspective
The global Oxiracetam API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oxiracetam API include Shaanxi Laon Biotech Co., Ltd., Shandong Green Chemical, Kono Chem Co.,Ltd., Chongqing Fuan Pharmaceutical, Union Pharma Co., Ltd., Shanghai CRM New Material Technology and Chemi SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oxiracetam API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oxiracetam API market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxiracetam API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxiracetam API.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Oxiracetam API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oxiracetam API Market by Company
Shaanxi Laon Biotech Co., Ltd.
Shandong Green Chemical
Kono Chem Co.,Ltd.
Chongqing Fuan Pharmaceutical
Union Pharma Co., Ltd.
Shanghai CRM New Material Technology
Chemi SpA
Oxiracetam API Segment by Type
Purity: 99%
Purity: >99%
Oxiracetam API Segment by Application
Oxiracetam Injection
Oxiracetam Tablets
Oxiracetam Capsules
Oxiracetam API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxiracetam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxiracetam API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxiracetam API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxiracetam API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oxiracetam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: 99%
- Purity: >99%
Applications
- Oxiracetam Injection
- Oxiracetam Tablets
- Oxiracetam Capsules
Companies covered
- Shaanxi Laon Biotech Co., Ltd.
- Shandong Green Chemical
- Kono Chem Co.,Ltd.
- Chongqing Fuan Pharmaceutical
- Union Pharma Co., Ltd.
- Shanghai CRM New Material Technology
- Chemi SpA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oxiracetam API Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oxiracetam API Sales Estimates and Forecasts (2021-2032)
- 1.3 Oxiracetam API Market by Type
- 1.3.1 Purity: 99%
- 1.3.2 Purity: >99%
- 1.4 Global Oxiracetam API Market Size by Type
- 1.4.1 Global Oxiracetam API Market Size Overview by Type (2021-2032)
- 1.4.2 Global Oxiracetam API Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Oxiracetam API Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Oxiracetam API Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Oxiracetam API Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Oxiracetam API Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Oxiracetam API Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Oxiracetam API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Oxiracetam API Industry Trends
- 2.2 Oxiracetam API Industry Drivers
- 2.3 Oxiracetam API Industry Opportunities and Challenges
- 2.4 Oxiracetam API Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Oxiracetam API Revenue (2021-2026)
- 3.2 Global Top Players by Oxiracetam API Sales (2021-2026)
- 3.3 Global Top Players by Oxiracetam API Price (2021-2026)
- 3.4 Global Oxiracetam API Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oxiracetam API Major Company Production Sites & Headquarters
- 3.6 Global Oxiracetam API Company, Product Type & Application
- 3.7 Global Oxiracetam API Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oxiracetam API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oxiracetam API Players Market Share by Revenue in 2025
- 3.8.3 2025 Oxiracetam API Tier 1, Tier 2, and Tier 3
4 Oxiracetam API Regional Status and Outlook
- 4.1 Global Oxiracetam API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Oxiracetam API Historic Market Size by Region
- 4.2.1 Global Oxiracetam API Sales in Volume by Region (2021-2026)
- 4.2.2 Global Oxiracetam API Sales in Value by Region (2021-2026)
- 4.2.3 Global Oxiracetam API Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Oxiracetam API Forecasted Market Size by Region
- 4.3.1 Global Oxiracetam API Sales in Volume by Region (2027-2032)
- 4.3.2 Global Oxiracetam API Sales in Value by Region (2027-2032)
- 4.3.3 Global Oxiracetam API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oxiracetam API by Application
- 5.1 Oxiracetam API Market by Application
- 5.1.1 Oxiracetam Injection
- 5.1.2 Oxiracetam Tablets
- 5.1.3 Oxiracetam Capsules
- 5.2 Global Oxiracetam API Market Size by Application
- 5.2.1 Global Oxiracetam API Market Size Overview by Application (2021-2032)
- 5.2.2 Global Oxiracetam API Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Oxiracetam API Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Oxiracetam API Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Oxiracetam API Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Oxiracetam API Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Oxiracetam API Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Oxiracetam API Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Shaanxi Laon Biotech Co., Ltd.
- 6.1.1 Shaanxi Laon Biotech Co., Ltd. Company Information
- 6.1.2 Shaanxi Laon Biotech Co., Ltd. Business Overview
- 6.1.3 Shaanxi Laon Biotech Co., Ltd. Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Shaanxi Laon Biotech Co., Ltd. Oxiracetam API Product Portfolio
- 6.1.5 Shaanxi Laon Biotech Co., Ltd. Recent Developments
- 6.2 Shandong Green Chemical
- 6.2.1 Shandong Green Chemical Company Information
- 6.2.2 Shandong Green Chemical Business Overview
- 6.2.3 Shandong Green Chemical Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shandong Green Chemical Oxiracetam API Product Portfolio
- 6.2.5 Shandong Green Chemical Recent Developments
- 6.3 Kono Chem Co.,Ltd.
- 6.3.1 Kono Chem Co.,Ltd. Company Information
- 6.3.2 Kono Chem Co.,Ltd. Business Overview
- 6.3.3 Kono Chem Co.,Ltd. Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Kono Chem Co.,Ltd. Oxiracetam API Product Portfolio
- 6.3.5 Kono Chem Co.,Ltd. Recent Developments
- 6.4 Chongqing Fuan Pharmaceutical
- 6.4.1 Chongqing Fuan Pharmaceutical Company Information
- 6.4.2 Chongqing Fuan Pharmaceutical Business Overview
- 6.4.3 Chongqing Fuan Pharmaceutical Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Chongqing Fuan Pharmaceutical Oxiracetam API Product Portfolio
- 6.4.5 Chongqing Fuan Pharmaceutical Recent Developments
- 6.5 Union Pharma Co., Ltd.
- 6.5.1 Union Pharma Co., Ltd. Company Information
- 6.5.2 Union Pharma Co., Ltd. Business Overview
- 6.5.3 Union Pharma Co., Ltd. Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Union Pharma Co., Ltd. Oxiracetam API Product Portfolio
- 6.5.5 Union Pharma Co., Ltd. Recent Developments
- 6.6 Shanghai CRM New Material Technology
- 6.6.1 Shanghai CRM New Material Technology Company Information
- 6.6.2 Shanghai CRM New Material Technology Business Overview
- 6.6.3 Shanghai CRM New Material Technology Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai CRM New Material Technology Oxiracetam API Product Portfolio
- 6.6.5 Shanghai CRM New Material Technology Recent Developments
- 6.7 Chemi SpA
- 6.7.1 Chemi SpA Company Information
- 6.7.2 Chemi SpA Business Overview
- 6.7.3 Chemi SpA Oxiracetam API Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Chemi SpA Oxiracetam API Product Portfolio
- 6.7.5 Chemi SpA Recent Developments
7 North America by Country
- 7.1 North America Oxiracetam API Sales by Country
- 7.1.1 North America Oxiracetam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Oxiracetam API Sales by Country (2021-2026)
- 7.1.3 North America Oxiracetam API Sales Forecast by Country (2027-2032)
- 7.2 North America Oxiracetam API Market Size by Country
- 7.2.1 North America Oxiracetam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Oxiracetam API Market Size by Country (2021-2026)
- 7.2.3 North America Oxiracetam API Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Oxiracetam API Sales by Country
- 8.1.1 Europe Oxiracetam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Oxiracetam API Sales by Country (2021-2026)
- 8.1.3 Europe Oxiracetam API Sales Forecast by Country (2027-2032)
- 8.2 Europe Oxiracetam API Market Size by Country
- 8.2.1 Europe Oxiracetam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Oxiracetam API Market Size by Country (2021-2026)
- 8.2.3 Europe Oxiracetam API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Oxiracetam API Sales by Country
- 9.1.1 Asia-Pacific Oxiracetam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Oxiracetam API Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Oxiracetam API Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Oxiracetam API Market Size by Country
- 9.2.1 Asia-Pacific Oxiracetam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Oxiracetam API Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Oxiracetam API Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Oxiracetam API Sales by Country
- 10.1.1 South America Oxiracetam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Oxiracetam API Sales by Country (2021-2026)
- 10.1.3 South America Oxiracetam API Sales Forecast by Country (2027-2032)
- 10.2 South America Oxiracetam API Market Size by Country
- 10.2.1 South America Oxiracetam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Oxiracetam API Market Size by Country (2021-2026)
- 10.2.3 South America Oxiracetam API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Oxiracetam API Sales by Country
- 11.1.1 Middle East and Africa Oxiracetam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Oxiracetam API Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Oxiracetam API Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Oxiracetam API Market Size by Country
- 11.2.1 Middle East and Africa Oxiracetam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Oxiracetam API Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Oxiracetam API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Oxiracetam API Value Chain Analysis
- 12.1.1 Oxiracetam API Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Oxiracetam API Production Mode & Process
- 12.2 Oxiracetam API Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Oxiracetam API Distributors
- 12.2.3 Oxiracetam API Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst